Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Vaccines news

Show

From To
J&J vaccine plus Gilead immune booster shows promise as HIV fighter

An experimental HIV vaccine from Johnson & Johnson combined with an immune system booster from Gilead Sciences Inc showed promise at keeping the virus at bay in monkeys even after treatments had stopped, marking yet another step toward the development of a so-called functional cure for HIV.

Published
10 November 2016
From
Reuters
Pneumococcal infections decrease in patients with suppressed HIV

Pneumococcal infections among patients with virologically suppressed HIV decreased significantly in recent years, according to data from a retrospective, case-controlled study.

Published
08 November 2016
From
Healio
Explainer: the how, what and why of the latest HIV vaccine trial

As the global quest for an HIV vaccine continues, Linda-Gail Bekker explains the significance of the latest large-scale trial underway in South Africa.

Published
01 November 2016
From
The Conversation
HPV vaccine works even better than expected, study finds

The vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, appears even more effective than believed, a new study finds. “After eight years of vaccination, the reduction in the incidence of cervical neoplasia [abnormal growth of cells], including pre-cancers, have been reduced approximately 50 percent. This is greater than what was expected – that’s pretty exciting,” said lead researcher Cosette Wheeler.

Published
04 October 2016
From
CBS
Broadly neutralizing HIV antibodies pave the way for vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zurich now reveal which factors are responsible for the human body forming such broadly neutralizing HIV antibodies, thereby opening new avenues for the development of an HIV vaccine.

Published
27 September 2016
From
Medical Xpress
Understanding the Rationale for the HVTN 702 Trial

What have scientists learned that helped inform the design of this pivotal AIDS vaccine study in South Africa?

Published
22 August 2016
From
Vax Report
New vigour in HIV vaccine research evident at AIDS 2016

Current and forthcoming studies of vaccines to prevent HIV infection have created a new optimism that the long and challenging road to the development of such a vaccine has begun to take some promising turns. Updates on the search for preventive vaccines, presented at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa, included information on advances in the development of novel vaccines, and in the field of antibody mediated prevention (AMP).

Published
19 July 2016
From
AIDS 2016
Treatment Action Group: Pipeline Report 2016

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Published
15 July 2016
From
Treatment Action Group
HIV study confirms clinically viable vaccine paving the way for future treatments

In the study, researchers worked with a species of Old World monkeys, rhesus macaques to reproduce the trial results of RV144, the only HIV vaccine that has been tested and shown to reduce the rate of HIV acquisition in a phase III clinical trial.

Published
08 July 2016
From
Eurekalert Inf Dis
Five Exciting HIV Prevention Studies We’re Paying Attention To

What’s on the horizon of HIV prevention? Here are five clinical trials to pay attention to, if you’re interested in what the next big breakthrough in the HIV prevention field may be.

Published
30 June 2016
From
BETA blog
← First12345...23Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.